| Treatment of type 2 diabetes: New clinical studies and effects of GLP-1 on macrovascular complications. | |
| | |
MedLine Citation:
|
PMID: 21030006 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Various publications in 2009 showed that the treatment of type 2 diabetic (T2D) patients with macrovascular complications is still a controversial subject, whether with regard to the use of glitazones, to the best management strategy for T2D patients with stable coronary artery disease or to the use of incretin mimetic drugs in patients with heart disease. The Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of glycemia in Diabetes study (RECORD) compared cardiovascular morbidity-mortality outcomes in patients taking rosiglitazone in combination with metformin or sulfonylurea versus metformin with sulfonylurea. The results showed that rosiglitazone was not inferior to the metformin-sulfonylurea combination in terms of mortality and cardiovascular hospitalization, but caution must be used when interpreting the results, as the event rate was low. The BARI 2D study (Bypass Angioplasty Revascularization Investigation 2 Diabetes) is a cardiovascular morbidity-mortality trial with the goal of determining the best strategy for blood glucose control and revascularization in T2D patients with stable coronary artery disease. The results of this trial showed that early revascularization is not clearly beneficial, except in a subgroup of patients in whom surgical revascularization is indicated. The use of GLP-1 analogs (Glucagon-Like Peptide-1) in the acute phase of myocardial ischemia in animal models provided promising results. Some clinical studies also suggest an improvement in cardiovascular risk factors with these treatments. Results from morbidity-mortality studies are needed to better assess the long-term efficiency of these new drugs. |
| | |
Authors:
|
S Lesven; J-F Gautier; R Maréchaud |
Related Documents
:
|
1296186 - The effect of sulphonylurea therapy on the outcome of coronary heart diseases in diabet... 10712326 - A randomized, prospective evaluation of noninvasive ventilation for acute respiratory f... 15048756 - Possum and p-possum for risk-adjusted audit of patients undergoing emergency laparotomy. 1556526 - Stroke following acute myocardial infarction in diabetics. 3526916 - Glucose alters configuration of gap junctions between pancreatic islet cells. 21291866 - Insulin increases glutamate transporter glt1 in cultured astrocytes. |
Publication Detail:
|
Type: Journal Article; Review Date: 2010-10-27 |
Journal Detail:
|
Title: Annales d'endocrinologie Volume: 71 ISSN: 0003-4266 ISO Abbreviation: Ann. Endocrinol. (Paris) Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-12-20 Completed Date: 2011-04-01 Revised Date: 2011-04-04 |
Medline Journal Info:
|
Nlm Unique ID: 0116744 Medline TA: Ann Endocrinol (Paris) Country: France |
Other Details:
|
Languages: eng Pagination: 505-10 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 Elsevier Masson SAS. All rights reserved. |
Affiliation:
|
CHU de la Cavale-Blanche, Brest, France. sandra.lesven@chu-brest.fr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Coronary Artery Disease / drug therapy, etiology Diabetes Mellitus, Type 2 / drug therapy*, pathology* Diabetic Angiopathies / drug therapy*, pathology* Glucagon-Like Peptide 1 / therapeutic use* Heart Diseases / drug therapy, etiology Humans Hypoglycemic Agents / adverse effects, therapeutic use Risk Factors Thiazolidinediones / adverse effects, therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Hypoglycemic Agents; 0/Thiazolidinediones; 122320-73-4/rosiglitazone; 89750-14-1/Glucagon-Like Peptide 1 |
| Comments/Corrections | |
Erratum In:
|
Ann Endocrinol (Paris). 2011 Feb;72(1):13 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Differential dynamics of spatial and non-spatial stimulus-response compatibility effects: A dual tas...
Next Document: Sequential induction of marrow stromal cells by FGF2 and BMP2 improves their growth and differentiat...